Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04245683 · ClinicalTrials.gov registry record
Feasibility of Non-Operative Management of Rectal Cancer in a Rural Population
A clinical trial of Rectal Cancer, sponsored by Bassett Healthcare.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT04245683 is a study of Rectal Cancer that is actively recruiting participants, run by Bassett Healthcare. The registered enrollment target is 50 participants, below the 3,166-participant average among 70 other Rectal Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04245683, a study of Rectal Cancer, is actively recruiting participants, sponsored by Bassett Healthcare.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an observational research study. Patients with rectal cancer can choose different courses of treatment. This study will follow these patients over the course of approximately six years, depending on their treatment. Patients will be monitored through clinic visits and survey assessments to see how they do, how they feel regarding their treatment choices, and their outcomes. The surveys will analyze the impact of the patients' treatment choices, as well as patient adherence, in a rural setting.
Conditions Studied
Interventions
- PROCEDURE Bowel/rectal resection
- OTHER non-operative follow up
Study Locations (1)
New York
- Bassett Healthcare Network - Cooperstown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2020-02-01 |
| Est. Completion | 2027-08-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04245683
The ClinicalTrials.gov registry entry for NCT04245683 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,166-participant average among 70 other Rectal Cancer trials with a reported enrollment target (98% lower). The listed sponsor is Bassett Healthcare, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Rectal Cancer appearing as the primary indexed condition, and to 2 interventions - of which Bowel/rectal resection is the first listed.
NCT04245683 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04245683 about?
NCT04245683 is a clinical study titled "Feasibility of Non-Operative Management of Rectal Cancer in a Rural Population". This is an observational research study. Patients with rectal cancer can choose different courses of treatment. This study will follow these patients over the course of approximately six years, depending on their treatment. Patients will be monitored through clinic visits and survey assessments to s...
What is the current status of trial NCT04245683?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2020-02-01. Estimated completion is 2027-08-01.
What conditions does trial NCT04245683 study?
This clinical trial studies the following conditions: Rectal Cancer.
What interventions are being tested in trial NCT04245683?
The interventions under investigation include: Bowel/rectal resection (PROCEDURE), non-operative follow up (OTHER).
Who is sponsoring clinical trial NCT04245683?
This trial is sponsored by Bassett Healthcare, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04245683 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
RECRUITING · Phase 1
-
Exosomes in Rectal Cancer
RECRUITING
-
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
RECRUITING · Phase 2
-
A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer.
RECRUITING · Phase 2
-
An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer
RECRUITING · NA
-
Ultrasound and Photoacoustic Imaging for Enhanced Differential Diagnosis of Rectal Cancer
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.